Tria; George Scott

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tria; George Scott.The latest application filed is for "locked nucleic acid cyclic dinucleotide compounds and uses thereof".

Company Profile

3.11.12

Tria; George Scott - Cambridge MA
Tria; George Scott - Arlington MA
Tria; George Scott - Princeton NJ
Tria; George Scott - La Jolla CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Locked nucleic acid cyclic dinucleotide compounds and uses thereof Grant 11,098,077 - Kanne , et al. August 24, 2	2021-08-24
Indole derivatives and uses thereof Grant 10,654,828 - Kerrigan , et al.	2020-05-19
Locked Nucleic Acid Cyclic Dinucleotide Compounds And Uses Thereof App 20190185511 - KANNE; David Braun ; et al.	2019-06-20
Indole Derivatives And Uses Thereof App 20190055219 - Kerrigan; John Ryan ; et al.	2019-02-21
Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders Grant 10,058,534 - Burks , et al. August 28, 2	2018-08-28
Benzothiophene Derivatives And Compositions Thereof As Selective Estrogen Receptor Degraders App 20180169063 - BURKS; Heather Elizabeth ; et al.	2018-06-21
Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders Grant 9,931,317 - Burks , et al. April 3, 2	2018-04-03
Benzothiophene Derivatives And Compositions Thereof As Selective Estrogen Receptor Degraders App 20170112805 - BURKS; Heather Elizabeth ; et al.	2017-04-27
Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders Grant 9,561,211 - Burks , et al. February 7, 2	2017-02-07
Benzothiophene Derivatives And Compositions Thereof As Selective Estrogen Receptor Degraders App 20160184265 - BURKS; Heather Elizabeth ; et al.	2016-06-30
Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders Grant 9,321,746 - Burks , et al. April 26, 2	2016-04-26
Benzothiophene Derivatives And Compositions Thereof As Selective Estrogen Receptor Degraders App 20150361065 - BURKS; Heather Elizabeth ; et al.	2015-12-17
Compounds and compositions as selective estrogen receptor degraders Grant 8,877,801 - Burks , et al. November 4, 2	2014-11-04
Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment App 20120178750 - Raghavan; Subharekha ; et al.	2012-07-12
Niacin receptor agonists, compositions containing such compounds and methods of treatment Grant 8,168,649 - Raghavan , et al. May 1, 2	2012-05-01
Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment App 20100144778 - Raghavan; Subharekha ; et al.	2010-06-10
Substituted pyrazoles, compositions containing such compounds and methods of use Grant 7,625,938 - Brockunier , et al. December 1, 2	2009-12-01
Substituted Pyrazoles, Compositions Containing such Compounds and Methods of Use App 20080108620 - Brockunier; Linda ; et al.	2008-05-08
Niacin receptor agonists, compositions containing such compounds and methods of treatment App 20060293364 - Raghavan; Subharekha ; et al.	2006-12-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.